Volume 68, Issue 3, Pages (September 2005)

Slides:



Advertisements
Similar presentations
Volume 64, Issue 6, Pages (December 2003)
Advertisements

Volume 65, Issue 4, Pages (April 2004)
Volume 57, Issue 2, Pages (October 2000)
Volume 82, Issue 2, Pages (July 2012)
Volume 79, Issue 9, Pages (May 2011)
Volume 78, Issue 2, Pages (July 2010)
Volume 55, Issue 6, Pages (June 1999)
Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice  Meera R. Krishnan, Congmiao.
Podocyte involvement in human immune crescentic glomerulonephritis
Volume 63, Issue 4, Pages (April 2003)
Volume 79, Issue 6, Pages (March 2011)
Retransplantation in Alport post-transplant anti-GBM disease
Jean Wu, Cindy Zhou, Julie Robertson, Colin Carlock, Ya-Huan Lou 
Volume 71, Issue 7, Pages (April 2007)
Volume 72, Issue 6, Pages (September 2007)
Volume 61, Issue 5, Pages (May 2002)
Volume 56, Issue 5, Pages (November 1999)
Volume 64, Issue 1, Pages (July 2003)
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
Volume 82, Issue 1, Pages (July 2012)
Volume 7, Issue 1, Pages (July 1997)
Durbaka V.R Prasad, Sabrina Richards, Xoi Muoi Mai, Chen Dong  Immunity 
Volume 63, Issue 4, Pages (April 2003)
Volume 75, Issue 10, Pages (May 2009)
Volume 72, Issue 7, Pages (October 2007)
Volume 63, Issue 1, Pages (January 2003)
Volume 66, Issue 5, Pages (November 2004)
Vitamin E treatment of experimental glomerular disease in rats
CD44-mediated neutrophil apoptosis in the rat
Volume 87, Issue 5, Pages (May 2015)
Volume 15, Issue 2, Pages (February 2007)
Lanlin Chen, Thomas Hellmark, Jörgen Wieslander, Warren Kline Bolton 
Volume 56, Issue 3, Pages (September 1999)
Volume 64, Issue 4, Pages (October 2003)
Volume 58, Issue 5, Pages (November 2000)
Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis  Paul Cockwell, Christopher J. Brooks, Dwomoa.
Volume 56, Issue 2, Pages (August 1999)
Volume 65, Issue 2, Pages (February 2004)
Volume 66, Issue 1, Pages (July 2004)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
Volume 67, Issue 2, Pages (February 2005)
Volume 70, Issue 7, Pages (October 2006)
Volume 54, Issue 5, Pages (November 1998)
Volume 70, Issue 2, Pages (July 2006)
Volume 63, Issue 1, Pages 1-11 (January 2003)
Volume 70, Issue 11, Pages (December 2006)
Regulatory interactions of αβ and γλ T cells in glomerulonephritis
Stephen R. Holdsworth, A. Richard Kitching, Peter G. Tipping 
Volume 53, Issue 5, Pages (May 1998)
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
Volume 68, Issue 2, Pages (August 2005)
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H–deficient mice  Jessy J. Alexander, Lee Chaves, Anthony Chang,
Volume 71, Issue 7, Pages (April 2007)
Volume 66, Issue 4, Pages (October 2004)
Volume 64, Issue 3, Pages (September 2003)
Adenosine A2A agonists as therapy for glomerulonephritis
AJKD Atlas of Renal Pathology: Anti–Glomerular Basement Membrane Antibody– Mediated Glomerulonephritis  Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian,
Shining a LAMP on pauci-immune focal segmental glomerulonephritis
Volume 67, Issue 3, Pages (March 2005)
Antiglomerular basement membrane disease with normal renal function
Volume 54, Pages S189-S191 (September 1998)
Red cell traverse through thin glomerular basement membrane
Volume 82, Issue 9, Pages (November 2012)
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 62, Issue 1, Pages (July 2002)
Volume 63, Issue 1, Pages (January 2003)
Gene targeting: Applications in transplantation research
T cells and T-cell receptors in acute renal failure
Volume 58, Issue 5, Pages (November 2000)
Presentation transcript:

Volume 68, Issue 3, Pages 1061-1070 (September 2005) Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis  Julie Robertson, Jean Wu, Jon Arends, William Glass, Scott Southwood, Alessandro Sette, Ya-Huan Lou, Dr  Kidney International  Volume 68, Issue 3, Pages 1061-1070 (September 2005) DOI: 10.1111/j.1523-1755.2005.00498.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Major histocompatability complex (MHC) class II restriction of T-cell epitope pCol(28-40). (A) T cells specific to pCol(28-40) are tested against pCol(28-40) using thymocytes as antigen-presenting cells in the presence of antibody to RT1.B or RT1.D; T-cell proliferation is measured by up-take of 3[H]-labeled thymidine. (B) Confocal micrograph showing binding of fluorescein isothiocyanate (FITC)-labeled pCol(28-40) to splenic macrophages from Wistar-Kyoto rat, but not to the macrophages from BN/SsNHsd rat (C). Kidney International 2005 68, 1061-1070DOI: (10.1111/j.1523-1755.2005.00498.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 T-cell epitope activity and nephritogenicity of three 11-mer peptides derived from pCol(28-40). (A) Response of pCol(28-40)-specific T cells to different peptides as indicated; T-cell responses are expressed as T-cell proliferation. (B) T-cell response to pCol(28-40) in the rats immunized with each of three 11-mer peptides as indicated. (C) Glomerulonephritis in the rats immunized with indicated peptides; severity of glomerulonephritis is expressed as average glomerular injury scores from 10 individuals. Kidney International 2005 68, 1061-1070DOI: (10.1111/j.1523-1755.2005.00498.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 T-cell response and glomerulonephritis induced by 10-mer peptide pCol(29-38). (A) Response of pCol(29-38)-specific T cells against pCol(28-40) and pCol(29-38). (B) Response of pCol(28-40)-specific T cells against pCol(28-40) and pCol(29-38); T-cell response to an irrelevant peptide CP2 is also shown. (C) Glomerulonephritis induced by pCol(29-38); severity of glomerulonephritis expressed as glomerular injury score; each open circle represents one experimental rat; horizontal bars indicate group averages (N = 10) (P = 0.45). (D) Renal histopathology showing glomerular injury in a rat immunized with pCol(29-38). The arrows delineate the cellular crescent and the asterisk overlies the injured and collapsed glomerular capillary tuft (bar = 50 μm). (E) Direct immunofluorescence on renal tissue of a pCol(29-38)-immunized rat showing linear binding of IgG to fragmented glomerular basement membrane (GBM). Kidney International 2005 68, 1061-1070DOI: (10.1111/j.1523-1755.2005.00498.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Cross-reactivity with T-cell epitope pCol(28-40), induction of T-cell responses, and nephritogenicity of the set of peptides with single substitution at each position of pCol(28-40). X axis indicates the position of the substituted residues. (A) Response of pCol(28-40)-specific T cells against the peptides with single substituted residue; horizontal line indicates the average of the T-cell response to pCol(28-40). (B) Reactivity of T cells from rats immunized with serial peptides with substituted residues against the immunogens (○) or pCol(28-40) (•). Horizontal line indicates the average of T-cell response in pCol(28-40)-immunized rats to pCol(28-40). (C) Glomerulonephritis in the rats immunized with serial peptides with substituted residues; severity of glomerulonephritis is expressed as average of glomerular injury scores of each peptide (six rats/peptide). Kidney International 2005 68, 1061-1070DOI: (10.1111/j.1523-1755.2005.00498.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 T-cell response in the rats immunized with pCol31A (A), pCol33A (B), and pCol34A (C). T cells were tested against pCol(28-40) (•) and immunizing peptides (○) as indicated. Kidney International 2005 68, 1061-1070DOI: (10.1111/j.1523-1755.2005.00498.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Antibody response and B-cell epitope specificity of the set of peptides with single residue substitution at each position of pCol(28-40). X axis indicates the position of the substituted residue. (A) Reactivity of pCol(28-40)-specific antibody to the serial peptides with substituted residues; the antibody activity was measured by enzyme-linked immunosorbent assay (ELISA). (B) Antibody response elicited by each peptide; antibody to pCol(28-40) or immunizing peptide was measured by ELISA; direct immunofluorescence of linear binding of anti-glomerular basement membrane (GBM) antibody to GBM is shown (▪, positive; □, negative). Kidney International 2005 68, 1061-1070DOI: (10.1111/j.1523-1755.2005.00498.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Schematic diagram of the structure of the nephritogenic T-cell epitope pCol(28-40). Closed circles are critical residues, while semicritical residues are indicated by gray color; lower case letters represent residues that are probably outside of major histocompatability complex (MHC) class II molecule RT.1Bl. Kidney International 2005 68, 1061-1070DOI: (10.1111/j.1523-1755.2005.00498.x) Copyright © 2005 International Society of Nephrology Terms and Conditions